Other immunohistochemistry-based studies that have examined the overall frequency of FGFR2 expression or overexpression in GC relative to normal gastric mucosa, have reported expression ranges between ~30% [45,46,47,48] to as high as 61% of tumours [49]. The gene discussed is FGFR2; the disease is neoplasm.